5 Multiple Myeloma Clinical Trials in The Bronx, NY (2026)

Q: How do I join a clinical trial in The Bronx?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the The Bronx research site will contact you.

Recruiting Multiple Myeloma Studies in The Bronx

NCT05591066Recruiting

The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now

In 2014, a team of parents, nurses, and physicians created Patient and Family Centered I-PASS (PFC I-PASS), a bundle of communication interventions to improve the quality of information exchange betwe...

The Bronx, NYNA14,400 participantsBoston Children's Hospital

View Study Details

NCT06266663Recruiting

Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease

Optimizing health related-quality of life (HRQoL) for patients with inflammatory bowel disease (IBD), who often experience a relapsing disease course, is an essential component of care. Improving IBD ...

The Bronx, NY400 participantsMontefiore Medical Center

View Study Details

NCT05862012Recruiting

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)

This study is a first-in-human, Phase 1, open-label study that will evaluate safety and anti-myeloma activity of ISB 2001 in participants with relapsed/refractory multiple myeloma (R/R MM)....

The Bronx, NYPHASE1200 participantsIchnos Sciences SA

View Study Details

NCT07007962Recruiting

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

This is a multinational, open label, single arm study that will evaluate the impact of early multi-immune modulation with rilzabrutinib in adult ITP patients who failed first-line treatment. The study...

The Bronx, NYPHASE360 participantsSanofi

View Study Details

NCT07104565Recruiting

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

This study will evaluate the safety and efficacy of tafasitamab in adult participants with primary autoimmune blood cell disorders....

The Bronx, NYPHASE256 participantsIncyte Corporation

View Study Details

About Multiple Myeloma Clinical Trials in The Bronx

Multiple myeloma is a cancer of plasma cells in the bone marrow that produce abnormal antibodies. It can cause bone damage, kidney problems, and immune deficiency. Treatments have advanced significantly with proteasome inhibitors, immunomodulatory drugs, and CAR-T cell therapy.

There are currently 5 multiple myeloma clinical trials recruiting participants in The Bronx, NY. These studies are seeking a combined 15,116 participants. Research is being sponsored by Boston Children's Hospital, Montefiore Medical Center, Ichnos Sciences SA and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Myeloma Clinical Trials in The Bronx — FAQ

Are there multiple myeloma clinical trials in The Bronx?

Yes, there are 5 multiple myeloma clinical trials currently recruiting in The Bronx, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in The Bronx?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the The Bronx research site will contact you about next steps.

Are clinical trials in The Bronx free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many The Bronx studies also compensate for your time and travel.

What multiple myeloma treatments are being tested?

The 5 active trials in The Bronx are testing new therapies including novel drugs, biologics, and treatment approaches for multiple myeloma.

Data updated July 16, 2026 from ClinicalTrials.gov